Fernand Labrie
Publications
Page 8 of 9, showing 50 records out of 429 total, starting on record 351, ending on 400
| Publication | Category | Year |
|---|---|---|
| 107. van der Kwast, T.H., Tetu, B., Fradet, Y., Dupont, A., Gomez, J., Cusan, L., Diamond, P., Labrie, F. (1996) Androgen receptor modulation in benign human prostatic tissue and prostatic adenocarcinoma during neoadjuvant endocrine combination therapy. Prostate, 28: 227-231. | Intracrinology | 1996 |
| 14. Vandenput, L., Labrie, F., Mellström, D., Swanson, C., Knutsson, T., Peeker, R., Ljunggren, O., Orwoll, E., Eriksson, A.L., Johnell, O., Damber, J.E., Ohlsson, C. (2007) Serum levels of specific glucuronidated androgen metabolites predict BMD and prostate volume in elderly men. J. of Bone and Mineral Research: The Official Journal of the American Soc. for Bone and Mineral Research, 22: 220-7. | Intracrinology | 2007 |
| 4721. Vandenput, L., Mellström, D, Karlsson, MK., Orwoll, E., Labrie, F., Ljunggren, O., Ohlsson C (2010) Serum estradiol is associated with lean mass in elderly Swedish men. European Journal of Endocrinology. 162: 737-745. | Intracrinology | 2010 |
| 949. Verreault, H., Dufort, I., Simard, J., Labrie, F., Luu-The, V. (1994) Dinucleotide repeat polymorphisms in the HSD3?2 gene. Hum. Mol. Genet., 3: 384. | Intracrinology | 1994 |
| 4719. Weirman, M.E., Nappi, R.E., Avis, N., Davis, S.R., Labrie F., Rosner, W., Shifren J.L. (2010) Endocrine aspects of women's sexual function. J Sex Med. 7:561-585. | Intracrinology | 2010 |
| 580. Yoshioka, M., Boivin, A., Ye, P., Labrie, F., St-Amand, J. (2006) Effects of dihydrotestosterone on skeletal muscle transcriptome measured by serial analysis of gene expression. J Mol Endocrinol, 36: 247-259. | Intracrinology | 2006 |
| 641. Young, J., Couzinet, B., Pholsena, M., Nahoul, K., Labrie, F., Schaison, G. (1994) Plasma 3β-hydroxy-?5-steroids in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab., 78: 299-304. | Intracrinology | 1994 |
| 951. Zerah, M., Rhéaume, E., Mani, P., Schram, P., Simard, J., Labrie, F., New, M.I. (1994) No evidence of mutations in the genes for type I and type II 3β-hydroxysteroid dehydrogenase (3β-HSD) in nonclassical 3β-HSD deficiency. J. Clin. Endocrinol. Metab., 79: 1811-1817. | Intracrinology | 1994 |
| 4684. Zhang, Y., Calvo, E., Martel, C., Luu-The, V., Labrie, F., Tchernof, A. (2008) Response of the adipose tissue transcriptome to dihydrotestosterone in mice. Physiol Genomics 35: 254-261 | Intracrinology | 2008 |
| 1017. Zhao, H.F., Labrie, C., Simard, J., de Launoit, Y., Trudel, C., Martel, C., Rhéaume, E., Dupont, E., Luu-The, V., Pelletier, G., Labrie, F. (1991) Characterization of rat 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase cDNAs and differential tissue-specific expression of corresponding mRNAs in steroidogenic and peripheral tissues. J. Biol. Chem., 266: 583-593. | Intracrinology | 1991 |
| 1052. Zhao, H.F., Rhéaume, E., Trudel, C., Couet, J., Labrie, F., Simard, J. (1990) Structure and sexual dimorphic expression of a liver-specific rat 3beta-hydroxysteroid dehydrogenase/isomerase. Endocrinology, 127: 3237-3239. | Intracrinology | 1990 |
| 952. Zhu, D.-W., Lee, X., Labrie, F., Lin, S.-X. (1994) Crystal growth of human estrogenic 17β-hydroxysteroid dehydrogenase. Acta Crystallogr., D50: 550-555. | Intracrinology | 1994 |
| 924. Zhu, D.-W., Zhou, M., Mao, Y., Labrie, F., Lin, S.-X. (1995) Crystallization of human estrogenic 17beta-hydroxysteroid dehydrogenase under microgravity. J. Cryst. Growth, 156: 108-111. | Intracrinology | 1995 |
| 199. Bégin, D., Luthy, I.A., Labrie, F. (1988) Adrenal precursor C19 steroids are potent stimulators of growth of androgen-sensitive mouse mammary carcinoma Shionogi cells in vitro. Mol. Cell. Endocrinol., 58: 213-219. | Intracrinology | 1988 |
| 926. Bernier, F., Leblanc, G., Labrie, F., Luu-The, V. (1994) Structure of human estrogen and aryl sulfotransferase gene: Two mRNA species issued from a single gene. J. Biol. Chem., 269: 28200-28205. | Intracrinology | 1994 |
| 1. Bydal, P., Luu-The, V., Labrie, F., Poirier, D. (2009) Steroidal lactones as inhibitors of 17beta-hydroxysteroid dehydrogenase type 5: Chemical synthesis, enzyme inhibitory activity, and assessment of estrogenic and androgenic activities. Eur J Med Chem.44:632-644. | Intracrinology | 2009 |
| 73. Chen, C., Li, X., Singh, S.M., Labrie, F. (1998) Activity of 17beta-(N-alkyl/arylformamido)- and 17beta-[(N-alkyl/aryl) alkyl/arylamido]-4-methyl-4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors in the hamster flank organ and ear. J. Invest. Dermatol., 111: 273-278. | Intracrinology | 1998 |
| 832. Coquet, A., Boudreau, N., Merand, Y., Labrie, F. (1998) Validated high-performance liquid chromatographic methods for quantitation of a novel nonsteroidal antiestrogen. J. Chromatogr. A, 828: 247-258. | Intracrinology | 1998 |
| 1070. Cusan, L., Dupont, A., Tremblay, R., Labrie, F. (1988) Treatment of hirsutism with the pure antiandrogen flutamide, in: Genazzani, A.R., Petraglia, F., Volpe, A. et Facchinetti, F., eds: Recent research on gynecological endocrinology: Selected free communications presented at the 1st Congress of the International Society of Gynecological Endocrinology, Crans-Montana, Switzerland, March 1988, pp 577-582. | Intracrinology | 1988 |
| 994. Dupont, A., Dupont, P., Cusan, L., Tremblay, M., Rioux, J., Cloutier, D., Mailloux, J., De Lignières, B., Gutkowska, J., Boucher, H., Bélanger, A., Moyer, D.L., Moorjani, S., Labrie, F. (1991) Comparative endocrinological and clinical effects of percutaneous estradiol and oral conjugated estrogens as replacement therapy in menopausal women. Maturitas, 13: 297-311. | Intracrinology | 1991 |
| 1071. Hubert, J.F., Thibault, L., Turcotte, R., Labrie, F. (1988) Androgens exert selective effects on protein kinase C-induced LH and FSH release in rat anterior pituitary cells in culture. Neuroendocrinology, 48: 360-366. | Intracrinology | 1988 |
| 4682. Ivanga, M., Labrie, Y., Calvo, E., Belleau, P., Martel, C., Pelletier, G., Morissette, J., Labrie, F., Durocher, F. (2009) Fine temporal analysis of DHT transcriptional modulation of the ATM/Gadd45g signaling pathways in the mouse uterus. Mol Reprod Dev, 76:278-288. | Intracrinology | 2009 |
| 205. Labrie, C., Bélanger, A., Labrie, F. (1988) Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology, 123: 1412-1417. | Intracrinology | 1988 |
| 181. Labrie, C., Simard, J., Marchetti, B., Pelletier, G., Zhao, H.F., Bélanger, A., Labrie, F. (1989) Conversion of precursor adrenal steroids into potent androgens in peripheral tissue, in: Labrie, F., Lee, F. et Dupont, A., eds: Early Stage Prostate Cancer: Diagnosis and Choice of Therapy, North Holland, Elsevier, ICS 841, pp 1-22. | Intracrinology | 1989 |
| 182. Labrie, C., Simard, J., Zhao, H., Bélanger, A., Pelletier, G., Labrie, F. (1989) Stimulation of androgen-dependent gene expression by the adrenal precursors dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology, 124: 2745-2754. | Intracrinology | 1989 |
| 75. Labrie, F. (1998) Combined androgen blockade and treatment of localized prostate cancer: a real hope when approaching the year 2000. Endocrine-Related Cancer, 5: 341-351. | Intracrinology | 1998 |
| 617. Labrie, F. (1998) DHEA as physiological replacement therapy at menopause. J. Endocrinol. Invest., 21: 399-401. | Intracrinology | 1998 |
| 76. Labrie, F. (1998) Optimizing combined androgen blockade in prostate cancer, in: Belldegrun, A., Kirby, R.S. et Oliver, R.T.D., eds: New Perspectives in Prostate Cancer, England, ISIS Medical Media, pp 293-311. | Intracrinology | 1998 |
| 59. Labrie, F. (1999) Combined androgen blockade: its unique efficacy for the treatment of localized prostate cancer, in: De Vita, V.T., Hellman, S. et Rosenberg, S.A., eds: Cancer: Principles and Practice of Oncology, Philadelphia, Lippincott-Raven, pp 1-9. | Intracrinology | 1999 |
| 611. Labrie, F. (1999) Potential of DHEA as hormone replacement therapy, in Reproductive Medicine: Past Present and Future. Proceeding of the 10th World Congress on Human Reproduction, Salvador, Bahia, Brazil, Parthenon Publishing, pp 224-237. | Intracrinology | 1999 |
| 60. Labrie, F. (1999) Prostate cancer: Endocrinology of prostate cancer-intracrinology, in: Pinchera, A., Bertega, X., Binder, C., Fischer, J. et Braverman, L., eds: Textbook of Clinical Endocrinology, Milan, Italy, McGraw-Hill Libri Italia Srl, pp 13-16. | Intracrinology | 1999 |
| 774. Labrie, F. (2001) Prostate cancer: Endocrinology of prostate cancer - intracrinology, in: Pinchera, A., Bertega, X., Binder, C., Fischer, J. et Braverman, L., eds: Endocrinology and Metabolism, pp 13-16. | Intracrinology | 2001 |
| 2. Labrie, F. (2008) Preface. Best Pract Res Clin Endocrinol Metab, 22: pp. vii-ix. | Intracrinology | 2008 |
| 77. Labrie, F., Bélanger, A., Luu-The, V., Labrie, C., Simard, J., Cusan, L., Gomez, J.L., Candas, B. (1998) DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids, 63: 322-328. | Intracrinology | 1998 |
| 612. Labrie, F., Bélanger, A., Luu-The, V., Labrie, C., Simard, J., Lin, S.-X. (1999) DHEA, the precursor of androgens and estrogens in peripheral tissues in the human: intracrinology, in: Kalimi, M. et Regelson, W., eds: Dehydroepiandrosterone (DHEA) Biochemical, Physiological and Clinical Aspects, Berlin, New York, Walter de Gruyter, pp 299-342. | Intracrinology | 1999 |
| 613. Labrie, F., Bélanger, A., Luu-The, V., Simard, J., Lin, S.-X., Cusan, L., Labrie, C. (1999) Role of DHEA transformation into androgens and estrogens in peripheral intracrine tissues, in: Thijssen, J.H.H. et Nieuwenhuyse, H., eds: DHEA a comprehensive review (Proceedings Workshop, Amsterdam 1997), New York, Parthenon Publishing, pp 69-103. | Intracrinology | 1999 |
| 206. Labrie, F., Bélanger, A., Veilleux, R., Lacoste, D., Labrie, C., Marchetti, B., Poulin, R., Dupont, A., Cusan, L., Luthy, I. (1988) Rationale for maximal androgen withdrawal in the therapy of prostate cancer, in: Furr, M. et Denis, L., eds: Baillieres Clinics in Oncology on Prostate Cancer, London, Saunders Company, pp 597-619. | Intracrinology | 1988 |
| 99. Labrie, F., Candas, B., Cusan, L., Diamond, P., Gomez, J.L. (1996) Antiandrogen story erred [Letter to the Editor]. The Medical Post, 32: | Intracrinology | 1996 |
| 161. Labrie, F., Dupont, A., Cusan, L., Manhès, G., Lacourcière, Y., Monfette, G., Emond, J. (1991) Maximal androgen blockade in prostate cancer: To-Day's Therapy of choice and 5-year clinical experience, in: Vickery, B.H. et Lunenfeld, B., eds: International Symposium on GnRH analogues in Cancer and Human Reproduction, The Netherlands, Kluwer Academic Publishers, pp 79-102. | Intracrinology | 1991 |
| 104. Labrie, F., Simard, J., Luu-The, V., Labrie, C., Bélanger, A. (1996) Adrenal androgens are responsible for 40-50% and not 5-10% of total prostatic androgens in 65-year-old men: intracrinology, in First International Consultation on Prostate Cancer, Monaco, pp Published on CD-ROM. | Intracrinology | 1996 |
| 821. Labrie, F., Simard, J., Pasqualini, J.R. (1999) Potential of DHEA as hormonal replacement therapy, 486 pages. | Intracrinology | 1999 |
| 214. Labrie, F., Veilleux, R., Fournier, A. (1988) Low androgen levels induce the development of androgen hypersensitive cell clones in Shionogi mouse mammary carcinoma cells in culture. J. Natl. Cancer Inst., 80: 1138-1147. | Intracrinology | 1988 |
| 215. Labrie, F., Veilleux, R., Fournier, A. (1988) Maintenance of androgen responsiveness by glucocorticoids in Shionogi mammary carcinoma cells in culture. J. Natl. Cancer Inst., 80: 966-970. | Intracrinology | 1988 |
| 192. Lacoste, D., Dubé, D., Bélanger, A., Labrie, F. (1989) Effect of 2-week combination therapy with the LHRH agonist [D-Trp6,des-Gly-NH2]LHRH ethylamide and the antiandrogen Flutamide on prostate structure and steroid levels in the dog. Mol. Cell. Endocrinol., 67: 131-138. | Intracrinology | 1989 |
| 218. Luthy, I., Bégin, D., Labrie, F. (1988) Mediation by the androgen receptor of the stimulatory and antiandrogenic actions of 17?-estradiol on the growth of androgen-sensitive Shionogi mammary carcinoma cells in culture. Endocrinology, 123: 1418-1424. | Intracrinology | 1988 |
| 219. Luthy, I.A., Bégin, D.J., Labrie, F. (1988) Androgenic activity of synthetic progestins and spironolactone in androgen-sensitive mouse mammary carcinoma (Shionogi) cells in culture. J. Steroid Biochem., 31: 845-852. | Intracrinology | 1988 |
| 4706. Luu-The, V., Duche, D., Ferraris, C., Meunier, J.R., Leclaire, J., Labrie, F. (2009) Expression profiles of phases 1 and 2 metabolizing enzymes in human skin and the reconstructed skin models EpiskinTM and RealskinTM. J of Ster Biochem and Mol Biol, 116: 178-186. | Intracrinology | 2009 |
| 221. Marchetti, B., Poulin, R., Plante, M., Labrie, F. (1988) Castration levels of plasma testosterone have potent stimulatory effects on androgen-sensitive parameters in the rat prostate. J. Steroid Biochem., 31: 411-419. | Intracrinology | 1988 |
| 222. Moorjani, S., Dupont, A., Labrie, F., Lupien, P.J., Gagné, C., Brun, D., Giguère, M., Bélanger, A., Cusan, L. (1988) Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma: effects of orchiectomy, estrogen and combination treatment with LHRH agonist and Flutamide. J. Clin. Endocrinol. Metab., 66: 314-322. | Intracrinology | 1988 |
| 223. Pelletier, G., Labrie, C., Simard, J., Duval, M., Martinoli, M.G., Zhao, H., Labrie, F. (1988) Effects of sex steroids on regulation of the levels of C1 peptide of rat prostatic steroid-binding protein mRNA evaluated by in situ hybridization. J. Mol. Endocrinol., 1: 213-223. | Intracrinology | 1988 |